These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12908492)

  • 21. The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain.
    Nuttall MC; Harris JP; Dawkins GP
    BJU Int; 2007 Feb; 99(2):243-4. PubMed ID: 17313420
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fulminant liver failure induced by flutamide].
    Rodríguez Gómez SJ; Martínez Moreno J; Martín Arribas MI; Pérez Villoria A; De la Serna Higuera C; Betancourt González A
    Rev Esp Enferm Dig; 2000 Jun; 92(6):411. PubMed ID: 10985104
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ischemic colitis after taking flutamide].
    Barouk J; Doubremelle M; Faroux R; Schnee M; Lafargue JP
    Gastroenterol Clin Biol; 1998 Oct; 22(10):841. PubMed ID: 9854217
    [No Abstract]   [Full Text] [Related]  

  • 24. Vitiliginous lesions after photosensitive dermatitis due to flutamide.
    Swoboda A; Kasche A; Baumstark J; Worret WI; Ring J; Eberlein-König B
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):681-2. PubMed ID: 17447984
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined androgen blockade: an update.
    Klotz L
    Urol Clin North Am; 2006 May; 33(2):161-6, v-vi. PubMed ID: 16631454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
    Whitaker HC; Hanrahan S; Totty N; Gamble SC; Waxman J; Cato AC; Hurst HC; Bevan CL
    Clin Cancer Res; 2004 Nov; 10(21):7392-401. PubMed ID: 15534116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of antiandrogens as therapy for women with polycystic ovary syndrome.
    Moghetti P
    Fertil Steril; 2006 Jul; 86 Suppl 1():S30-1. PubMed ID: 16798285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bicalutamide.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17458049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bicalutamide-associated fulminant hepatotoxicity.
    O'Bryant CL; Flaig TW; Utz KJ
    Pharmacotherapy; 2008 Aug; 28(8):1071-5. PubMed ID: 18657023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is photopatch testing useful in the investigation of photosensitivity due to flutamide?
    Martín-Lázaro J; Buján JG; Arrondo AP; Lozano JR; Galindo EC; Capdevila EF
    Contact Dermatitis; 2004 May; 50(5):325-6. PubMed ID: 15209825
    [No Abstract]   [Full Text] [Related]  

  • 31. [Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation].
    Abdah-Bortnyak R; Bernstein Z; Ramon N; Zalman D; Shnaider J; Kuten A
    Harefuah; 2007 Feb; 146(2):126-8, 164-5. PubMed ID: 17352282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
    Van Poppel H
    Eur Urol; 2007 Jul; 52(1):115. PubMed ID: 17270341
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiandrogens prevent stable DNA-binding of the androgen receptor.
    Farla P; Hersmus R; Trapman J; Houtsmuller AB
    J Cell Sci; 2005 Sep; 118(Pt 18):4187-98. PubMed ID: 16141232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.
    Ibáñez L; Jaramillo A; Ferrer A; de Zegher F
    Hum Reprod; 2005 Jul; 20(7):1833-6. PubMed ID: 15802316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade.
    Tanvetyanon T; Choudhury AM
    J Urol; 2004 Apr; 171(4):1627. PubMed ID: 15017238
    [No Abstract]   [Full Text] [Related]  

  • 36. Comment: clinical experiences of visual disturbances with nilutamide.
    Dijkman GA; Klotz LH; Diokno AC; Zippe CD
    Ann Pharmacother; 1997 Dec; 31(12):1550-2. PubMed ID: 9416403
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of mutant androgen receptors by flutamide.
    Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
    Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatotoxicity from flutamide].
    Cantalejo Moreira M; García Espinosa V; Martín Gutiérrez JC; García Puig J
    Med Clin (Barc); 1997 Dec; 109(20):819-20. PubMed ID: 9493165
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostate cancer tissue is masked by bicalutamide: a case report.
    Ellinger J; Bastian PJ; Biermann K; Schmidt ME; Textor J; Bollmann D; Zhou H; Müller SC
    Eur J Med Res; 2007 May; 12(5):212-5. PubMed ID: 17513193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of bicalutamide-induced breast events.
    Sieber PR
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1773-9. PubMed ID: 18062751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.